表紙
市場調查報告書

乾癬治療藥的全球市場:產業分析,規模,佔有率,成長,趨勢,及預測(2019年∼2027年)

Psoriasis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 422942
出版日期 內容資訊 英文 200 Pages
商品交期: 最快1-2個工作天內
價格
乾癬治療藥的全球市場:產業分析,規模,佔有率,成長,趨勢,及預測(2019年∼2027年) Psoriasis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2019年10月23日內容資訊: 英文 200 Pages
簡介

本報告提供全球乾癬治療藥市場的相關調查,提供市場機會,成長及阻礙因素,藥物類別·給藥途徑·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 市場定義·範圍
  • 市場區隔
  • 主要的調查目的
  • 調查亮點

第2章 前提條件·調查方法

第3章 摘要整理

第4章 市場概要

  • 概要
    • 市場定義
    • 產業的發展/開發
  • 概要
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 市場分析·預測
    • 市場收益預測

第5章 主要洞察

  • 地區/各主要國家的法規方案
  • 乾癬治療藥市場開發平台分析
  • 主要的合併·收購

第6章 市場分析:各類藥物

  • 概要·定義
  • 主要調查結果/開發
  • 市場銷售額預測
    • TNF抑制劑
    • 白細胞介素抑制劑
    • 維他命 D 類比製劑
    • 皮質類固醇
    • 其他
  • 市場魅力

第7章 市場分析:各給藥途徑

  • 概要·定義
  • 主要調查結果/開發
  • 市場銷售額預測
    • 口服
    • 非口服
    • 局部
  • 市場魅力

第8章 市場分析:各流通管道

  • 概要·定義
  • 主要調查結果/開發
  • 市場銷售額預測
    • 醫院藥局
    • 零售藥局
    • 其他
  • 市場魅力

第9章 市場分析:各地區

  • 主要調查結果
  • 市場銷售額預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力

第10章 北美

第11章 歐洲

第12章 亞太地區

第13章 南美

第14章 中東·非洲

第15章 競爭情形

  • 市場佔有率分析:各企業
  • 企業簡介
    • Amgen, Inc.
    • Eli Lilly and Company
    • Novartis AG
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Pfizer, Inc.
    • AstraZeneca plc
    • AbbVie, Inc.
    • LEO Pharma A/S
    • Biogen, Inc.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Psoriasis Treatment Market - Scope of the Report

TMR'S report on the global psoriasis treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global psoriasis treatment market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast end-year. The report also provides the compound annual growth rate (CAGR) for the global psoriasis treatment market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global psoriasis treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approach to study various phenomena in the global psoriasis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global psoriasis treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global psoriasis treatment market. The next section of the global psoriasis treatment report highlights the USPs, which include regulatory scenarios for psoriasis treatment, globally, psoriasis treatment pipeline analysis, and potential mergers & acquisition in the global psoriasis treatment market.

The report delves into the competitive landscape of the global psoriasis treatment market. Key players operating in the global psoriasis treatment market have been identified, and each one of these have been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOT are some of the attributes of the players profiled in the global psoriasis treatment market report.

Key Questions Answered in Global Psoriasis Treatment Market Report

What is the sales/revenue expected to be generated by psoriasis treatment products across all the regions during the forecast period?

What are the key trends in the psoriasis treatment market?

What are the major drivers, restraints, and opportunities in the market?

Which region is set to expand at the fastest CAGR during the forecast period?

Which segment will have the highest revenue, globally, in 2027, and which product will expand at the fastest CAGR during the forecast period?

Psoriasis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global psoriasis treatment market begins with an overview of the said market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of this study, and the healthcare compliances laid down by accredited agencies in the purview of research. It is followed by market introduction, market dynamics, and an overview of the global psoriasis treatment market, which includes TMR's analysis of the market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights have been provided to understand the Y-o-Y trends of the psoriasis treatment market. The next section of the global psoriasis treatment report highlights the USPs, which include regulatory scenarios for psoriasis treatment, globally, psoriasis treatment pipeline analysis, and key mergers & acquisitions in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of the key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key psoriasis treatment market manufacturers have been mapped to ascertain the size of the global psoriasis treatment market in terms of value. The forecasts presented here assess the total revenue generated in the psoriasis treatment market. In order to provide an accurate forecast, we initiated by sizing up the current psoriasis treatment market with the help of the parent market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Psoriasis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Market Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Psoriasis Treatment Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Regulatory Scenario by Region/Key Country
  • 5.2. Psoriasis Treatment Market Pipeline Analysis
  • 5.3. Key Mergers & Acquisitions

6. Global Psoriasis Treatment Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
    • 6.3.1. TNF Inhibitors
    • 6.3.2. Interleukin Inhibitors
    • 6.3.3. Vitamin D Analogs
    • 6.3.4. Corticosteroids
    • 6.3.5. Others
  • 6.4. Market Attractiveness, by Drug Class

7. Global Psoriasis Treatment Market Analysis and Forecast, by Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Topical
  • 7.4. Market Attractiveness By Route of Administration

8. Global Psoriasis Treatment Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Others
  • 8.4. Market Attractiveness, by Distribution Channel

9. Global Psoriasis Treatment Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Psoriasis Treatment Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Region

10. North America Psoriasis Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
    • 10.2.1. TNF Inhibitors
    • 10.2.2. Interleukin Inhibitors
    • 10.2.3. Vitamin D Analogs
    • 10.2.4. Corticosteroids
    • 10.2.5. Others
  • 10.3. North America Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
    • 10.3.1. Oral
    • 10.3.2. Parenteral
    • 10.3.3. Topical
  • 10.4. North America Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Others
  • 10.5. North America Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Psoriasis Treatment Market Attractiveness Analysis
    • 10.6.1. By Drug Class
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Psoriasis Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
    • 11.1.2. Others
  • 11.2. Europe Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
    • 11.2.1. TNF Inhibitors
    • 11.2.2. Interleukin Inhibitors
    • 11.2.3. Vitamin D Analogs
    • 11.2.4. Corticosteroids
    • 11.2.5. Others
  • 11.3. Europe Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
    • 11.3.1. Oral
    • 11.3.2. Parenteral
    • 11.3.3. Topical
  • 11.4. Europe Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Others
  • 11.5. Europe Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Psoriasis Treatment Market Attractiveness Analysis
    • 11.6.1. By Drug Class
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Psoriasis Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
    • 12.2.1. TNF Inhibitors
    • 12.2.2. Interleukin Inhibitors
    • 12.2.3. Vitamin D Analogs
    • 12.2.4. Corticosteroids
    • 12.2.5. Others
  • 12.3. Asia Pacific Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
    • 12.3.1. Oral
    • 12.3.2. Parenteral
    • 12.3.3. Topical
  • 12.4. Asia Pacific Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Others
  • 12.5. Asia Pacific Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Psoriasis Treatment Market Attractiveness Analysis
    • 12.6.1. By Drug Class
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Psoriasis Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Latin America Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
    • 13.2.1. TNF Inhibitors
    • 13.2.2. Interleukin Inhibitors
    • 13.2.3. Vitamin D Analogs
    • 13.2.4. Corticosteroids
    • 13.2.5. Others
  • 13.3. Latin America Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
    • 13.3.1. Oral
    • 13.3.2. Parenteral
    • 13.3.3. Topical
  • 13.4. Latin America Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Others
  • 13.5. Latin America Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Psoriasis Treatment Market Attractiveness Analysis
    • 13.6.1. By Drug Class
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Psoriasis Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
    • 14.2.1. TNF Inhibitors
    • 14.2.2. Interleukin Inhibitors
    • 14.2.3. Vitamin D Analogs
    • 14.2.4. Corticosteroids
    • 14.2.5. Others
  • 14.3. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
    • 14.3.1. Oral
    • 14.3.2. Parenteral
    • 14.3.3. Topical
  • 14.4. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Others
  • 14.5. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis
    • 14.6.1. By Drug Class
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Share Analysis, by Company, 2018
  • 15.2. Company Profiles
    • 15.2.1. Amgen, Inc.
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. Strategic Overview
      • 15.2.1.5. SWOT Analysis
    • 15.2.2. Eli Lilly and Company
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Financial Overview
      • 15.2.2.3. Product Portfolio
      • 15.2.2.4. Strategic Overview
      • 15.2.2.5. SWOT Analysis
    • 15.2.3. Novartis AG
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Financial Overview
      • 15.2.3.3. Product Portfolio
      • 15.2.3.4. Strategic Overview
      • 15.2.3.5. SWOT Analysis
    • 15.2.4. Merck & Co., Inc.
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Financial Overview
      • 15.2.4.3. Product Portfolio
      • 15.2.4.4. Strategic Overview
      • 15.2.4.5. SWOT Analysis
    • 15.2.5. Johnson & Johnson
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Financial Overview
      • 15.2.5.3. Product Portfolio
      • 15.2.5.4. Strategic Overview
      • 15.2.5.5. SWOT Analysis
    • 15.2.6. Pfizer, Inc.
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Financial Overview
      • 15.2.6.3. Product Portfolio
      • 15.2.6.4. Strategic Overview
      • 15.2.6.5. SWOT Analysis
    • 15.2.7. AstraZeneca plc
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Financial Overview
      • 15.2.7.3. Product Portfolio
      • 15.2.7.4. Strategic Overview
      • 15.2.7.5. SWOT Analysis
    • 15.2.8. AbbVie, Inc.
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Financial Overview
      • 15.2.8.3. Product Portfolio
      • 15.2.8.4. Strategic Overview
      • 15.2.8.5. SWOT Analysis
    • 15.2.9. LEO Pharma A/S
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Financial Overview
      • 15.2.9.3. Product Portfolio
      • 15.2.9.4. Strategic Overview
      • 15.2.9.5. SWOT Analysis
    • 15.2.10. Biogen, Inc.
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Financial Overview
      • 15.2.10.3. Product Portfolio
      • 15.2.10.4. Strategic Overview
      • 15.2.10.5. SWOT Analysis

List of Tables

  • Table 01: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 02: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 03: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 04: Global Psoriasis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 05: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 06: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 07: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 08: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 09: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 10: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 11: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 12: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 13: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 14: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 15: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 16: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 17: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 18: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 19: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 20: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 21: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 22: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 23: Middle East & Africa Psoriasis Treatment Market Value(US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 24: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

List of Figures

  • Figure 01: Global Psoriasis Treatment Market Snapshot, 2018
  • Figure 02: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2017-2027
  • Figure 04: Global Psoriasis Treatment Market Value Share, by Route of Administration, 2018
  • Figure 06: Global Psoriasis Treatment Market Value Share, by Region, 2018
  • Figure 03: Global Psoriasis Treatment Market Value Share, by Drug Class, 2018
  • Figure 05: Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2018
  • Figure 07: Regulatory Approval Process - U.S.
  • Figure 08: Regulatory Approval Process - Europe
  • Figure 09: Regulatory Approval Process - Japan
  • Figure 10: Global Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027
  • Figure 11: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by TNF Inhibitors, 2017-2027
  • Figure 12: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Interleukin Inhibitors, 2017-2027
  • Figure 13: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin D Analogs, 2017-2027
  • Figure 14: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2017-2027
  • Figure 15: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 16: Global Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 17: Global Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 18: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017-2027
  • Figure 19: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral, 2017-2027
  • Figure 20: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical, 2017-2027
  • Figure 21: Global Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 22: Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 23: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017-2027
  • Figure 24: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017-2027
  • Figure 25: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 26: Global Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 27: Global Psoriasis Treatment Market Value Share, by Region, 2018 and 2027
  • Figure 28: Global Psoriasis Treatment Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 29: North America Psoriasis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2027
  • Figure 30: North America Psoriasis Treatment Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 31: North America Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027
  • Figure 32: North America Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 33: North America Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 34: North America Psoriasis Treatment Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 35: North America Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 36: North America Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 37: North America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 38: Europe Psoriasis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 39: Europe Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 40: Europe Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027
  • Figure 41: Europe Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 42: Europe Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 43: Europe Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration
  • Figure 44: Europe Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 45: Europe Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 46: Europe Psoriasis Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 47: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 48: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 49: Asia Pacific Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027
  • Figure 50: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 51: Asia Pacific Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 52: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 53: Asia Pacific Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 54: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 55: Asia Pacific Psoriasis Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 56: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2027
  • Figure 57: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 58: Latin America Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027
  • Figure 59: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 60: Latin America Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 61: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration
  • Figure 62: Latin America Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 63: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
  • Figure 64: Latin America Psoriasis Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 65: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 66: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 67: Middle East & Africa Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027
  • Figure 68: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 69: Middle East & Africa Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 70: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 71: Middle East & Africa Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 72: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 73: Middle East & Africa Market Value Share, by Country/Sub-region, 2018 and 2027